Foldax this week announced that India’s medical device regulatory body approved initiation of a clinical trial to study its Tria biopolymer surgical aortic heart valve.
Salt Lake City-based Foldax designed the Tria heart valve to resist calcification, withstand stresses and strains without failure and restore patient quality of life without the lifelong use of anticoagulants.
Get the full story on our sister site, Medical Tubing + Extrusion.